Clinical Trials Logo

Clinical Trial Summary

Objective of the study is to compare the efficacy and safety of 'Short duration antibiotic' (72hrs) and 'Standard duration antibiotic'(5 - 7days) in preterm neonates ( >28weeks and >1000grams ) with culture negative early onset sepsis.


Clinical Trial Description

Enrolled participants will be randomly allocated to one of two study groups: 1) Short duration antibiotic' (72hrs), 2) Standard duration antibiotic'(5 - 7days) Short duration antibiotic group: Antibiotic therapy stopped at the time of randomization i.e. 72 hours after starting antibiotics Standard duration antibiotic group: antibiotics therapy continued for 5-7 days further after 72 hrs of starting antibiotics. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06197269
Study type Interventional
Source Lady Hardinge Medical College
Contact Sushma Nangia, DM (Neo)
Phone 9810838181
Email drsnangia@gmail.com
Status Recruiting
Phase N/A
Start date April 15, 2022
Completion date April 14, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06076200 - Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
Completed NCT03694613 - Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants N/A
Recruiting NCT03819192 - Predicting EONS in PPROM Patients
Recruiting NCT03997266 - NICU Antibiotics and Outcomes Trial Phase 4
Recruiting NCT05329701 - Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns. Phase 4
Not yet recruiting NCT06377397 - Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates Phase 3
Not yet recruiting NCT06100614 - Presepsin to Safely Reduce Antibiotics in Preterm Infants N/A
Not yet recruiting NCT05796115 - PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS N/A